nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftazidime—SLC22A6—Adefovir Dipivoxil—hepatitis B	0.494	0.63	CbGbCtD
Ceftazidime—SLC22A6—Lamivudine—hepatitis B	0.29	0.37	CbGbCtD
Ceftazidime—Nephropathy toxic—Adefovir Dipivoxil—hepatitis B	0.0123	0.057	CcSEcCtD
Ceftazidime—Hepatic function abnormal—Adefovir Dipivoxil—hepatitis B	0.00588	0.0272	CcSEcCtD
Ceftazidime—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.0054	0.025	CcSEcCtD
Ceftazidime—Renal impairment—Telbivudine—hepatitis B	0.00454	0.021	CcSEcCtD
Ceftazidime—Neutropenia—Entecavir—hepatitis B	0.00425	0.0197	CcSEcCtD
Ceftazidime—Renal failure—Entecavir—hepatitis B	0.00399	0.0184	CcSEcCtD
Ceftazidime—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00389	0.018	CcSEcCtD
Ceftazidime—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00386	0.0178	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Entecavir—hepatitis B	0.00384	0.0177	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00374	0.0173	CcSEcCtD
Ceftazidime—Neutropenia—Telbivudine—hepatitis B	0.00349	0.0162	CcSEcCtD
Ceftazidime—Inflammation—Lamivudine—hepatitis B	0.00346	0.016	CcSEcCtD
Ceftazidime—Immune system disorder—Entecavir—hepatitis B	0.00329	0.0152	CcSEcCtD
Ceftazidime—Renal failure—Telbivudine—hepatitis B	0.00328	0.0152	CcSEcCtD
Ceftazidime—Aplastic anaemia—Lamivudine—hepatitis B	0.00315	0.0146	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Telbivudine—hepatitis B	0.00315	0.0146	CcSEcCtD
Ceftazidime—Leukopenia—Entecavir—hepatitis B	0.00284	0.0131	CcSEcCtD
Ceftazidime—Phlebitis—Lamivudine—hepatitis B	0.00283	0.0131	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00268	0.0124	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00261	0.0121	CcSEcCtD
Ceftazidime—Anaphylactic shock—Entecavir—hepatitis B	0.00259	0.012	CcSEcCtD
Ceftazidime—Renal impairment—Lamivudine—hepatitis B	0.00256	0.0118	CcSEcCtD
Ceftazidime—Dysgeusia—Telbivudine—hepatitis B	0.00255	0.0118	CcSEcCtD
Ceftazidime—Nervous system disorder—Entecavir—hepatitis B	0.00254	0.0117	CcSEcCtD
Ceftazidime—Skin disorder—Entecavir—hepatitis B	0.00251	0.0116	CcSEcCtD
Ceftazidime—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00248	0.0114	CcSEcCtD
Ceftazidime—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00247	0.0114	CcSEcCtD
Ceftazidime—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00245	0.0113	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Entecavir—hepatitis B	0.00223	0.0103	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.0022	0.0102	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00218	0.0101	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Entecavir—hepatitis B	0.00212	0.00978	CcSEcCtD
Ceftazidime—Nervous system disorder—Telbivudine—hepatitis B	0.00208	0.00964	CcSEcCtD
Ceftazidime—Thrombocytopenia—Telbivudine—hepatitis B	0.00208	0.00962	CcSEcCtD
Ceftazidime—Skin disorder—Telbivudine—hepatitis B	0.00206	0.00955	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00206	0.00955	CcSEcCtD
Ceftazidime—Body temperature increased—Entecavir—hepatitis B	0.00205	0.00946	CcSEcCtD
Ceftazidime—Abdominal pain—Entecavir—hepatitis B	0.00205	0.00946	CcSEcCtD
Ceftazidime—Pancytopenia—Lamivudine—hepatitis B	0.002	0.00925	CcSEcCtD
Ceftazidime—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.002	0.00923	CcSEcCtD
Ceftazidime—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.002	0.00923	CcSEcCtD
Ceftazidime—Neutropenia—Lamivudine—hepatitis B	0.00197	0.00911	CcSEcCtD
Ceftazidime—Paraesthesia—Telbivudine—hepatitis B	0.00191	0.00883	CcSEcCtD
Ceftazidime—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00186	0.00861	CcSEcCtD
Ceftazidime—Renal failure—Lamivudine—hepatitis B	0.00185	0.00854	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00183	0.00849	CcSEcCtD
Ceftazidime—Jaundice—Lamivudine—hepatitis B	0.00183	0.00847	CcSEcCtD
Ceftazidime—Pain—Telbivudine—hepatitis B	0.00182	0.00841	CcSEcCtD
Ceftazidime—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00179	0.00826	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Lamivudine—hepatitis B	0.00178	0.00821	CcSEcCtD
Ceftazidime—Diarrhoea—Entecavir—hepatitis B	0.00177	0.00819	CcSEcCtD
Ceftazidime—Agranulocytosis—Lamivudine—hepatitis B	0.00175	0.00811	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Telbivudine—hepatitis B	0.00174	0.00804	CcSEcCtD
Ceftazidime—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00173	0.00799	CcSEcCtD
Ceftazidime—Dizziness—Entecavir—hepatitis B	0.00171	0.00791	CcSEcCtD
Ceftazidime—Abdominal pain—Telbivudine—hepatitis B	0.00168	0.00777	CcSEcCtD
Ceftazidime—Body temperature increased—Telbivudine—hepatitis B	0.00168	0.00777	CcSEcCtD
Ceftazidime—Vomiting—Entecavir—hepatitis B	0.00164	0.00761	CcSEcCtD
Ceftazidime—Rash—Entecavir—hepatitis B	0.00163	0.00754	CcSEcCtD
Ceftazidime—Dermatitis—Entecavir—hepatitis B	0.00163	0.00754	CcSEcCtD
Ceftazidime—Headache—Entecavir—hepatitis B	0.00162	0.0075	CcSEcCtD
Ceftazidime—Vomiting—Adefovir Dipivoxil—hepatitis B	0.0016	0.00742	CcSEcCtD
Ceftazidime—Erythema multiforme—Lamivudine—hepatitis B	0.00159	0.00737	CcSEcCtD
Ceftazidime—Rash—Adefovir Dipivoxil—hepatitis B	0.00159	0.00736	CcSEcCtD
Ceftazidime—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00159	0.00735	CcSEcCtD
Ceftazidime—Headache—Adefovir Dipivoxil—hepatitis B	0.00158	0.00731	CcSEcCtD
Ceftazidime—Nausea—Entecavir—hepatitis B	0.00154	0.00711	CcSEcCtD
Ceftazidime—Immune system disorder—Lamivudine—hepatitis B	0.00152	0.00704	CcSEcCtD
Ceftazidime—Pruritus—Telbivudine—hepatitis B	0.0015	0.00695	CcSEcCtD
Ceftazidime—Nausea—Adefovir Dipivoxil—hepatitis B	0.0015	0.00693	CcSEcCtD
Ceftazidime—Diarrhoea—Telbivudine—hepatitis B	0.00145	0.00673	CcSEcCtD
Ceftazidime—Dysgeusia—Lamivudine—hepatitis B	0.00144	0.00665	CcSEcCtD
Ceftazidime—Dizziness—Telbivudine—hepatitis B	0.00141	0.0065	CcSEcCtD
Ceftazidime—Tremor—Lamivudine—hepatitis B	0.00137	0.00636	CcSEcCtD
Ceftazidime—Vomiting—Telbivudine—hepatitis B	0.00135	0.00625	CcSEcCtD
Ceftazidime—Angioedema—Lamivudine—hepatitis B	0.00134	0.0062	CcSEcCtD
Ceftazidime—Rash—Telbivudine—hepatitis B	0.00134	0.0062	CcSEcCtD
Ceftazidime—Dermatitis—Telbivudine—hepatitis B	0.00134	0.00619	CcSEcCtD
Ceftazidime—Headache—Telbivudine—hepatitis B	0.00133	0.00616	CcSEcCtD
Ceftazidime—Leukopenia—Lamivudine—hepatitis B	0.00131	0.00608	CcSEcCtD
Ceftazidime—Convulsion—Lamivudine—hepatitis B	0.00127	0.00588	CcSEcCtD
Ceftazidime—Nausea—Telbivudine—hepatitis B	0.00126	0.00584	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00124	0.00574	CcSEcCtD
Ceftazidime—Anaphylactic shock—Lamivudine—hepatitis B	0.0012	0.00554	CcSEcCtD
Ceftazidime—Nervous system disorder—Lamivudine—hepatitis B	0.00117	0.00543	CcSEcCtD
Ceftazidime—Thrombocytopenia—Lamivudine—hepatitis B	0.00117	0.00542	CcSEcCtD
Ceftazidime—Skin disorder—Lamivudine—hepatitis B	0.00116	0.00538	CcSEcCtD
Ceftazidime—Hypotension—Lamivudine—hepatitis B	0.00112	0.00518	CcSEcCtD
Ceftazidime—Paraesthesia—Lamivudine—hepatitis B	0.00108	0.00497	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00103	0.00478	CcSEcCtD
Ceftazidime—Pain—Lamivudine—hepatitis B	0.00102	0.00474	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Lamivudine—hepatitis B	0.000979	0.00453	CcSEcCtD
Ceftazidime—Urticaria—Lamivudine—hepatitis B	0.000952	0.0044	CcSEcCtD
Ceftazidime—Abdominal pain—Lamivudine—hepatitis B	0.000947	0.00438	CcSEcCtD
Ceftazidime—Body temperature increased—Lamivudine—hepatitis B	0.000947	0.00438	CcSEcCtD
Ceftazidime—Hypersensitivity—Lamivudine—hepatitis B	0.000882	0.00408	CcSEcCtD
Ceftazidime—Pruritus—Lamivudine—hepatitis B	0.000847	0.00392	CcSEcCtD
Ceftazidime—Diarrhoea—Lamivudine—hepatitis B	0.00082	0.00379	CcSEcCtD
Ceftazidime—Dizziness—Lamivudine—hepatitis B	0.000792	0.00366	CcSEcCtD
Ceftazidime—Vomiting—Lamivudine—hepatitis B	0.000762	0.00352	CcSEcCtD
Ceftazidime—Rash—Lamivudine—hepatitis B	0.000755	0.00349	CcSEcCtD
Ceftazidime—Dermatitis—Lamivudine—hepatitis B	0.000754	0.00349	CcSEcCtD
Ceftazidime—Headache—Lamivudine—hepatitis B	0.00075	0.00347	CcSEcCtD
Ceftazidime—Nausea—Lamivudine—hepatitis B	0.000711	0.00329	CcSEcCtD
